247 related articles for article (PubMed ID: 4109186)
1. Routine tests as measures of the total intrinsic blood clotting potential. A comparison of whole blood clotting time (WBCT), recalcification time of citrated plasma (RTST), partial thromboplastin time (PTT), and activated partial thromboplastin time (APTT).
Korsan-Bengtsen K
Scand J Haematol; 1971; 8(5):359-68. PubMed ID: 4109186
[No Abstract] [Full Text] [Related]
2. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
Hjorth B; Kjaersgaard E
Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
[TBL] [Abstract][Full Text] [Related]
3. Whole-blood clotting time, activated partial thromboplastin time, and whole-blood recalcification time as heparin monitoring tests.
Ts'ao CH; Galluzzo TS; Lo R; Peterson KG
Am J Clin Pathol; 1979 Jan; 71(1):17-21. PubMed ID: 420167
[TBL] [Abstract][Full Text] [Related]
4. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels.
Reed RL; Bracey AW; Hudson JD; Miller TA; Fischer RP
Circ Shock; 1990 Oct; 32(2):141-52. PubMed ID: 2253317
[TBL] [Abstract][Full Text] [Related]
5. Comparison between British Comparative Thromboplastin (BCT) and a factor II-VII-X determination method (simplastin A) based on fresh plasma samples from dicoumarol-treated patients.
Korsan-Bengtsen K; Johsen M; Pehrsson NG
Thromb Haemost; 1977 Feb; 37(1):98-103. PubMed ID: 65801
[TBL] [Abstract][Full Text] [Related]
6. The activated partial thromboplastin time as a monitor of heparin therapy: a warning.
Makary AZ; Waterbury L
Johns Hopkins Med J; 1977 Jun; 140(6):311-5. PubMed ID: 864903
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
Parsi K; Exner T; Connor DE; Ma DD; Joseph JE
Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):731-40. PubMed ID: 17919946
[TBL] [Abstract][Full Text] [Related]
8. The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects.
Jepsen S; Hansen AB
Scand J Clin Lab Invest; 1994 Nov; 54(7):543-7. PubMed ID: 7863231
[TBL] [Abstract][Full Text] [Related]
9. [Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)].
Fischer M; Falkensammer C
Wien Klin Wochenschr; 1974 Oct; 86(19):577-83. PubMed ID: 4432516
[No Abstract] [Full Text] [Related]
10. Measurement of prothrombin time and activated partial thromboplastin time in citrated whole blood samples from clinically ill dogs following storage.
Maunder CL; Costa M; Cue SM; Crawford EM; Papasouliotis K; Murphy KF
J Small Anim Pract; 2012 Sep; 53(9):531-5. PubMed ID: 22860986
[TBL] [Abstract][Full Text] [Related]
11. Kinetic aspects of the interaction of blood-clotting enzymes. II. The relation between clotting time and plasma concentration in prothrombin-time estimations.
Hemker HC; Siepel T; Altman R; Loeliger EA
Thromb Diath Haemorrh; 1967 May; 17(3-4):349-57. PubMed ID: 5589294
[No Abstract] [Full Text] [Related]
12. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. I. Correlations between the variables of clotting and fibrinolysis.
Korsan-Bengtsen K; Wilhelmsen L; Tibblin G
Thromb Diath Haemorrh; 1972 Aug; 28(1):89-98. PubMed ID: 5074993
[No Abstract] [Full Text] [Related]
13. Comparison of prothrombin time and activated partial thromboplastin time on Dade Auto-FI and Bio-Quest Fibrometer.
Villa L; Ibanez J; Castro A
Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):165-73. PubMed ID: 663397
[TBL] [Abstract][Full Text] [Related]
14. Changes in anticoagulation in dogs assayed by three methods.
Harrison HN; Gutterman B; Haynie M; Weintraub H; Brandt B
Lab Anim Sci; 1976 Dec; 26(6 Pt 1):917-21. PubMed ID: 1018478
[TBL] [Abstract][Full Text] [Related]
15. Clotting alterations in primary systemic amyloidosis.
Gamba G; Montani N; Anesi E; Palladini G; Capezzera M; Soldavini E; Merlini G
Haematologica; 2000 Mar; 85(3):289-92. PubMed ID: 10702818
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of high-concentration calcium chloride solution for correction of activated partial thromboplastin time (APTT) in patients with high-hematocrit value.
Kanahara M; Kai H; Okamura T; Wada T; Suda K; Imaizumi T; Sagawa K
Thromb Res; 2008; 121(6):781-5. PubMed ID: 17904620
[TBL] [Abstract][Full Text] [Related]
17. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
[TBL] [Abstract][Full Text] [Related]
18. The partial thromboplastin time in the CAP survey program.
Koepke JA
Am J Clin Pathol; 1975 Jun; 63(6 SUPPL):990-4. PubMed ID: 1146770
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative estimation of preanalytical variables which may influence the determinations of prothrombin time (PT) and activated partial thromboplastin time (APTT)].
Isa K; Yamauchi MS; Nago TT; Yamane N
Rinsho Byori; 2010 Oct; 58(10):979-85. PubMed ID: 21077287
[TBL] [Abstract][Full Text] [Related]
20. [A new system of analysis for partial thromboplastin time. Comparison with other blood coagulation tests in liver diseases].
Pagliano FM; Slucca P; Cestari G
Arch Sci Med (Torino); 1976; 133(4):321-5. PubMed ID: 1023840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
